Medy-Tox Inc. (KOSDAQ:086900)

Medy-Tox Revenue

Medy-Tox had revenue of 60.69B KRW in the quarter ending March 31, 2026, a decrease of -5.11%. This brings the company's revenue in the last twelve months to 244.02B, up 2.53% year-over-year. In the year 2025, Medy-Tox had annual revenue of 247.29B with 8.17% growth.

• Revenue (ttm): 244.02B
• Revenue Growth: +2.53%
• P/S Ratio: 2.28
• Revenue / Employee: 339.86M
• Employees: 718
• Market Cap: 557.19B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	247.29B	18.67B	8.17%
Dec 31, 2024	228.62B	7.50B	3.39%
Dec 31, 2023	221.12B	26.02B	13.34%
Dec 31, 2022	195.10B	10.23B	5.53%
Dec 31, 2021	184.87B	44.04B	31.27%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 11, 2026

Data Sources Report a data error